quizartinib,Cytarabine,Idarubicin
daiichi sankyo
['quizartinib']
#eha2023: exciting to see results of quiwi: survival advantage for quizartinib added to intensive chemo in flt3-itd-neg patients. the curves in eln-17 favorable are impressive. is this due to inhibition of flt3wt or other kinases? confirmation certainly needed! 
Physician-scientist, leukemia geneticist, amateur photographer